Reflex Conditioning for Cerebral Palsy
(SRC-CP Trial)
Trial Summary
What is the purpose of this trial?
This trial involves training reflexes to reduce muscle tightness in adults with spastic Cerebral Palsy. The treatment uses exercises to help the body learn to control muscle tightness better. If successful, it could offer a new, non-invasive way to improve movement and daily activities for these patients.
Will I have to stop taking my current medications?
No, you will not have to stop taking your current medications. The trial requires that your current medication remains unchanged for 3 months.
What data supports the effectiveness of the treatment Soleus Stretch Reflex Operant Conditioning for cerebral palsy?
Research shows that operant conditioning of the soleus stretch reflex can change reflex size, which is related to motor function, and may improve movement rehabilitation in people with central nervous system disorders. Additionally, a study found that feedback training to reduce the stretch reflex gain significantly decreased spasticity in individuals with cerebral palsy.12345
Is reflex conditioning for cerebral palsy safe for humans?
Research shows that reflex conditioning, like the soleus H-reflex operant conditioning, does not cause long-term changes in muscle reflexes or disturb normal movement in healthy people. Additionally, studies on people with cerebral palsy indicate that reflex training can reduce muscle stiffness without harmful effects.12456
How is the Soleus Stretch Reflex Operant Conditioning treatment different from other treatments for cerebral palsy?
This treatment is unique because it uses operant conditioning to change the size of the soleus stretch reflex, which can improve motor function by enhancing the brain and spinal cord's ability to adapt and learn new motor skills. Unlike other treatments, it focuses on modifying reflex pathways directly related to movement, potentially offering a novel approach to rehabilitation for cerebral palsy.12347
Research Team
Kathleen Friel, PhD
Principal Investigator
Burke Neurological Institute
Eligibility Criteria
Adults over 18 with spastic Cerebral Palsy, able to walk at least 10 meters with or without help. They should be classified as level I-III in motor function and not planning any medication changes for three months. Participants must not be pregnant, have uncontrolled diabetes, skin disorders, heart conditions, latex allergies, recent Botox treatments or surgeries on the affected leg.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete 6 baseline sessions to establish initial reflex measurements
Treatment
Participants undergo 24 down conditioning sessions to decrease the magnitude of the H-Reflex
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Soleus Stretch Reflex Operant Conditioning (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Burke Medical Research Institute
Lead Sponsor